The analysis involved patients in the investigational device exemption study assessing Medtronic’s Prestige cervical disc.
The Spine Journal published the study.
Here are six notes:
1. In the base-case analysis, the researchers found a 40-year-old experienced a five-year cost of:
• $116,717 for ACDF
• $130,417 for CDR
2. CDR yielded 3.45 quality-adjusted life years and ACDF saw 3.23 QALYS.
3. The study revealed CDR’s incremental cost-effectiveness ratio was $62,337 per QALY.
4. Researchers found the Monte Carlo simulation validated the base-case scenario.
5. Based on a $100,000 per QALY willingness to pay, CDR proved to be more cost-effective.
6. The researchers concluded both two-level CDR and ACDF are cost-effective at five years.
More articles on spine:
Texas Medical Board suspends neurosurgeon’s license following child sexual assault arrest: 5 key notes
Jeopardy! host undergoes surgery to remove subdural hematoma: 4 things to know
Top 10 Spine Review articles: Jan. 1-5
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.